Suchergebnisse - "Yuan, Guosheng"

PubPharm (40)

1

A novel engineered IL-21 receptor arms T-cell receptor-engineered T cells (TCR-T cells) against hepatocellular carcinoma

enthalten in: Signal transduction and targeted therapy | 2024

von Zhu, W. | Zhang, Z. | Chen, J. | +21

2

Transarterial chemoembolization with/without immune checkpoint inhibitors plus tyrosine kinase inhibitors for unresectable hepatocellular carcinoma : a single center, propensity score matching real-world study

enthalten in: Discover. Oncology | 2024

von Yuan, G. | Li, W. | Zang, M. | +8

3

Transarterial chemoembolization with/without immune checkpoint inhibitors plus tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: a single center, propensity score matching real-world study

enthalten in: Discover oncology | 2024

von Yuan, G. | Li, W. | Zang, M. | +8

4

Spleen-dedicated stiffness measurement performed well to rule out high-risk varices in HBV-related hepatocellular carcinoma : Screening for high-risk varices in HCC

enthalten in: Alimentary pharmacology & therapeutics | 2024

von Cheng, X. | Tang, Y. | He, Q. | +24

5

Spleen‐dedicated stiffness measurement performed well to rule out high‐risk varices in HBV‐related hepatocellular carcinoma

enthalten in: Alimentary Pharmacology & Therapeutics | 2024

von Cheng, X. | Tang, Y. | He, Q. | +24

6

enthalten in: Alimentary Pharmacology & Therapeutics | 2024

von Cheng, X. | Tang, Y. | He, Q. | +24

7

Tyrosine kinase inhibitors, immune checkpoint inhibitors combined with hepatic arterial infusion of oxaliplatin and raltitrexed versus oxaliplatin, 5-fluorouracil and leucovorin for intermediate and advanced hepatocellular carcinoma : A retrospective study

enthalten in: International immunopharmacology | 2023

von Zang, M. | Hu, X. | Yuan, G. | +5

8

Sorafenib plus drug-eluting bead transarterial chemoembolization for early intrahepatic stage-progressed advanced hepatocellular carcinoma refractory to conventional transarterial chemoembolization

enthalten in: Journal of cancer research and clinical oncology | 2023

von Fan, W. | Zhu, B. | Zheng, X. | +11

9

Identifying optimal candidates for post-TIPS patients with HCC undergoing TACE : a multicenter observational study

enthalten in: European radiology | 2023

von Fan, W. | Zhu, B. | Yue, S. | +20

10

Interaction between baseline HBV loads and the prognosis of patients with HCC receiving anti-PD-1 in combination with antiangiogenic therapy undergoing concurrent TAF prophylaxis

enthalten in: BMC infectious diseases | 2022

von Hu, X. | Li, R. | Li, Q. | +3